Interspecies scaling: Predicting volumes, mean residence time and elimination half-life. Some suggestions

被引:42
作者
Mahmood, I [1 ]
机构
[1] US FDA, Off Clin Pharmacol & Biopharmaceut, Div Pharmaceut Evaluat 1, Woodmont Off Ctr 2, Rockville, MD 20852 USA
关键词
D O I
10.1111/j.2042-7158.1998.tb06190.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Extrapolation of animal data to assess pharmacokinetic parameters in man is an important tool in drug development. Clearance, volume of distribution and elimination half-life are the three most frequently extrapolated pharmacokinetic parameters. Extensive work has been done to improve the predictive performance of allometric scaling for clearance. In general there is good correlation between body weight and volume, hence volume in man can be predicted with reasonable accuracy from animal data. Besides the volume of distribution in the central compartment (V-c), two other volume terms, the volume of distribution by area (V-beta) and the volume of distribution at steady state (Vd(ss)), are also extrapolated from animals to man. This report compares the predictive performance of allometric scaling for V-c, V-beta and Vd(ss) in man from animal data. The relationship between elimination half-life (t1/2) and body weight across species results in poor correlation, most probably because of the hybrid nature of this parameter. To predict half-life in man from animal data, an indirect method (CL=VK, where CL=clearance, V is volume and K is elimination rate constant) has been proposed. This report proposes another indirect method which uses the mean residence time (MRT). After establishing that MRT can be predicted across species, it was used to predict half-life using the equation MRT = 1.44 x t1/2. The results of the study indicate that V, is predicted more accurately than Vp and Vdss in man. It should be emphasized that for first-time dosing in man, V,is a more important pharmacokinetic parameter than Vp or Vdss. Furthermore, MRT can be predicted reasonably well for man and can be used for prediction of half-life.
引用
收藏
页码:493 / 499
页数:7
相关论文
共 36 条
[1]   DISPOSITION OF CIPROFLOXACIN FOLLOWING INTRAVENOUS ADMINISTRATION IN DOGS [J].
ABADIA, AR ;
ARAMAYONA, JJ ;
MUNOZ, MJ ;
DELFINA, JMP ;
SAEZ, MP ;
BREGANTE, MA .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1994, 17 (05) :384-388
[2]  
Aramayona JJ, 1996, AM J VET RES, V57, P547
[3]  
AWANI WM, 1985, DRUG METAB DISPOS, V13, P133
[5]   INTERSPECIES COMPARISON OF INVIVO CAFFEINE PHARMACOKINETICS IN MAN, MONKEY, RABBIT, RAT, AND MOUSE [J].
BONATI, M ;
LATINI, R ;
TOGNONI, G ;
YOUNG, JF ;
GARATTINI, S .
DRUG METABOLISM REVIEWS, 1985, 15 (07) :1355-1383
[6]   SCALING OF ANTIPYRINE INTRINSIC CLEARANCE OF UNBOUND DRUG IN 15 MAMMALIAN-SPECIES [J].
BOXENBAUM, H ;
FERTIG, JB .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1984, 9 (02) :177-183
[7]   INTERSPECIES PHARMACOKINETIC SCALING AND THE EVOLUTIONARY-COMPARATIVE PARADIGM [J].
BOXENBAUM, H .
DRUG METABOLISM REVIEWS, 1984, 15 (5-6) :1071-1121
[8]   INTERSPECIES SCALING, ALLOMETRY, PHYSIOLOGICAL TIME, AND THE GROUND PLAN OF PHARMACOKINETICS [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (02) :201-225
[9]   INTERSPECIES PHARMACOKINETIC SCALING OF SCH-34343 [J].
CHUNG, M ;
RADWANSKI, E ;
LOEBENBERG, D ;
LIN, CC ;
ODEN, E ;
SYMCHOWICZ, S ;
GURAL, RP ;
MILLER, GH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 :227-233
[10]   DOSE RANGING STUDY AND CONSTANT INFUSION EVALUATION OF CIPROFLOXACIN [J].
DRUSANO, GL ;
PLAISANCE, KI ;
FORREST, A ;
STANDIFORD, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (03) :440-443